Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Efe Özgür SERİNAN"'
Autor:
Tekincan Çağrı Aktaş, Safiye Aktaş, Efe Özgür Serinan, Pınar Erçetin, Melek Aydın, Özde Elif Gökbayrak, Aylin Erol, Zekiye Altun, Nur Olgun
Publikováno v:
Journal of Behçet Uz Children's Hospital, Vol 13, Iss 2, Pp 123-129 (2023)
Objective: Tumor heterogeneity describes the differences between cancer cells in the same tumor sample. Neuroblastoma (NB) is a type of cancer where tumor heterogeneity complicates its treatment. This study aims to explore the role of molecular heter
Externí odkaz:
https://doaj.org/article/d76e64c9844f43b5a25f0407274c3403
Autor:
Asuman Feda BAYRAK, Yuksel OLGUN, Hande EVİN ESKİCİOĞLU, Selen KUM ÖZŞENGEZER, Efe Özgür SERİNAN, Hatice Efsun KOLATAN, Hasan Oğuz ÇETİNAYAK, Günay KIRKIM, Safiye AKTAŞ, Osman YILMAZ, Nur OLGUN, Zekiye ALTUN
Publikováno v:
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi.
Amaç: Darbepoetin-alfa (DPO) uygulamasının sisplatine bağlı ototoksik etkiyi önleyici rolü olup olmadığının in-vivo olarak değerlendirilmesi amaçlandı. Materyal metod: Çalışmada 28 adet wistar albino rat kullanılarak 4 grup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5d7d3c244286851feb22f7d6986ae22
https://doi.org/10.18614/deutip.1231950
https://doi.org/10.18614/deutip.1231950
Publikováno v:
Proceedings, Vol 2, Iss 25, p 1538 (2018)
Recent studies have shown that cancer cells can deceive phagocytosing macrophage cells through the CD47 protein which gives the message “don’t eat me” or “don’t kill me” to immune components. The efficacy of anti-CD47 treatment approach w
Externí odkaz:
https://doaj.org/article/1c5ebc83c4164053a036a8b001e83e94
Publikováno v:
Proceedings, Vol 2, Iss 25, p 1591 (2018)
Neuroblastoma is an embryonic tumor originating from the neural crest. It accounts for 8–10% of all childhood cancers. Although Cisplatin is used in neuroblastoma treatment, it has many side effects, such as ototoxicity, nephrotoxicity, and neuroto
Externí odkaz:
https://doaj.org/article/a7ae1527ba384330839c842fb88dde44